The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer
Open accessAbstract
Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin cells or similar cells in extra-adrenal sympathetic and parasympathetic paraganglia, respectively. Serious morbidity and mortality rates associated with these tumors are related to the potent effects of catecholamines on various organs, especially those of the cardiovascular system. Before any surgical procedure is done, preoperative blockade is necessary to protect the patient against significant release of catecholamines due to anesthesia and surgical manipulation of the tumor. Treatment options vary with the extent of the disease, with laparoscopic surgery being the preferred treatment for removal of primary tumors. Medullary thyroid cancer (MTC) is a malignancy of the thyroid C cells or parafollicular cells. Thyroid C cells elaborate a number of peptides and hormones, such as calcitonin, carcinoembryonic antigen, and chromogranin A. Some or all of these markers are elevated in patients with MTC and can be used to confirm the diagnosis as well as to follow patients longitudinally for recurrence. Medullary thyroid cancer consists of a spectrum of diseases that ranges from extremely indolent tumors that are stable for many years to aggressive types associated with a high mortality rate. Genetic testing for RET mutations has allowed identification of familial cases and prophylactic thyroidectomy for cure. The only curative treatment is complete surgical resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Self-citationGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Self-citationGenetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A.-P., Grossman, A. B., Kimura, N., Mannelli, M., McNicol, A. M., & Tischler, A. S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0396 · Cited by 680
Self-citationPreoperative Management of the Pheochromocytoma Patient
Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1720 · Cited by 576
Self-citationClinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
Roman, S., Lin, R., & Sosa, J. A. (2006) · Cancer · doi:10.1002/cncr.22244 · Cited by 548
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 542
Wells, S. A., Gosnell, J. E., Gagel, R. F., Moley, J., Pfister, D., Sosa, J. A., Skinner, M., Krebs, A., Vasselli, J., & Schlumberger, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6604 · Cited by 519
Sawka, A. M., Jaeschke, R., Singh, R. J., & Young, W. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021251 · Cited by 503
Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
Eisenhofer, G., Goldstein, D. S., Walther, M. M., Friberg, P., Lenders, J. W. M., Keiser, H. R., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030005 · Cited by 492
Self-citationMotesanib Diphosphate in Progressive Differentiated Thyroid Cancer
Sherman, S. I., Wirth, L. J., Droz, J.-P., Hofmann, M., Bastholt, L., Martins, R. G., Licitra, L., Eschenberg, M. J., Sun, Y.-N., Juan, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075853 · Cited by 470
Clinical Experience Over 48 Years With Pheochromocytoma
Goldstein, R. E., O’Neill, J. A., Holcomb, G. W., Morgan, W. M., Neblett, W. W., Oates, J. A., Brown, N., Nadeau, J., Smith, B., Page, D. L., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00001 · Cited by 464
Averbuch, S. D., Steakley, C. S., Young, R. C., Gelmann, E. P., Goldstein, D. S., Stull, R., & Keiser, H. R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-267 · Cited by 427
Barbet, J., Campion, L., Kraeber-Bodéré, F., & Chatal, J.-F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0044 · Cited by 407
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
Skinner, M. A., Moley, J. A., Dilley, W. G., Owzar, K., DeBenedetti, M. K., & Wells, S. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043999 · Cited by 381
Scollo, C., Baudin, E., Travagli, J.-P., Caillou, B., Bellon, N., Leboulleux, S., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021713 · Cited by 369
Eisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 349
Schlumberger, M. J., Elisei, R., Bastholt, L., Wirth, L. J., Martins, R. G., Locati, L. D., Jarzab, B., Pacini, F., Daumerie, C., Droz, J.-P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7815 · Cited by 340
Timmers, H. J. L. M., Kozupa, A., Chen, C. C., Carrasquillo, J. A., Ling, A., Eisenhofer, G., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6297 · Cited by 340
Self-citationPheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
Hoegerle, S., Nitzsche, E., Altehoefer, C., Ghanem, N., Manz, T., Brink, I., Reincke, M., Moser, E., & Neumann, H. P. H. (2002) · Radiology · doi:10.1148/radiol.2222010622 · Cited by 325
Brouwers, F. M., Eisenhofer, G., Tao, J. J., Kant, J. A., Adams, K. T., Linehan, W. M., & Pacak, K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0423 · Cited by 316
Self-citationPheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 305
Kouvaraki, M. A., Shapiro, S. E., Perrier, N. D., Cote, G. J., Gagel, R. F., Hoff, A. O., Sherman, S. I., Lee, J. E., & Evans, D. B. (2005) · Thyroid · doi:10.1089/thy.2005.15.531 · Cited by 288
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 276
Self-citationCohen, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.919 · Cited by 274
[123I]Metaiodobenzylguanidine and[111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas1
van der Harst, E., de Herder, W. W., Bruining, H. A., Bonjer, H. J., de Krijger, R. R., Lamberts, S. W. J., van de Meiracker, A. H., Boomsma, F., Stijnen, T., Krenning, E. P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7238 · Cited by 253
Pheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis
Hansford, J. R., & Mulligan, L. M. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.817 · Cited by 241
Ilias, I., Yu, J., Carrasquillo, J. A., Chen, C. C., Eisenhofer, G., Whatley, M., McElroy, B., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030235 · Cited by 241
Self-citationCurrent Management of Medullary Thyroid Cancer
Sippel, R. S., Kunnimalaiyaan, M., & Chen, H. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0239 · Cited by 181
Self-citationA Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma
de Groot, J. W. B., Zonnenberg, B. A., van Ufford-Mannesse, P. Q., de Vries, M. M., Links, T. P., Lips, C. J. M., & Voest, E. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0649 · Cited by 180
Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor
Elder, E. E., Elder, G., & Larsson, C. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20177 · Cited by 173
van Essen, M., Krenning, E. P., Kooij, P. P. M., Bakker, W. H., Feelders, R. A., de Herder, W. W., Wolbers, J. G., & Kwekkeboom, D. J. (2006) · PubMed · Cited by 161
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
Pacák, K., Eisenhofer, G., & Goldstein, D. S. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0032 · Cited by 154
Characteristics of Pheochromocytoma in a 4‐ to 20‐Year‐Old Population
Barontini, M., Levin, G. M., & Sansó, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.003 · Cited by 143
Manger, W. M., & Gifford, R. W. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.01452.x · Cited by 143
[123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas
van der Harst, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.685 · Cited by 131
Bhatia, K. S. S., Ismail, M., Sahdev, A., Rockall, A., Hogarth, K. M., Canizales, A., Avril, N. E., Monson, J. P., Grossman, A. B., & Reznek, R. H. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03256.x · Cited by 127
Biochemical Diagnosis and Localization of Pheochromocytoma
Grossman, A. B., Pacák, K., Sawka, A. M., Lenders, J. W. M., HARLANDER, D., Peaston, R., Reznek, R. H., Sisson, J. C., & Eisenhofer, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.038 · Cited by 127
Kunnimalaiyaan, M., Vaccaro, A. M., Ndiaye, M. A., & Chen, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603578200 · Cited by 126
Self-citationUtility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
Weise, M., Merke, D. P., Pacák, K., Walther, M. M., & Eisenhofer, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8446 · Cited by 123
Is Supine Rest Necessary before Blood Sampling for Plasma Metanephrines?
Lenders, J. W. M., Willemsen, J. J., Eisenhofer, G., Ross, H. A., Pacák, K., Timmers, H. J. L. M., & Sweep, F. C. G. J. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.076489 · Cited by 120
Timmers, H. J. L. M., Hadi, M., Carrasquillo, J. A., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042721 · Cited by 114
Lumachi, F., Tregnaghi, A., Zucchetta, P., Marzola, M. C., Cecchin, D., Grassetto, G., & Bui, F. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200607000-00006 · Cited by 113
Shulkin, B. L., Koeppe, R. A., Francis, I. R., et al. (1993) · Radiology · doi:10.1148/radiology.186.3.8430179 · Cited by 94
Medullary thyroid cancer: therapeutic targets and molecular markers
Ball, D. W. (2006) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32801173ea · Cited by 94
Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice
Zelinka, T., Eisenhofer, G., & Pacák, K. (2007) · Stress · doi:10.1080/10253890701395896 · Cited by 84
van der Horst‐Schrivers, A. N. A., Jager, P. L., Boezen, H. M., Schouten, J. P., Kema, I. P., & Links, T. P. (2006) · PubMed · Cited by 77
Surgical management of patients with persistent or recurrent medullary thyroid cancer
Moley, DeBenedetti, Dilley, Tisell, & Wells (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00333.x · Cited by 75
Recent advances in the diagnosis and treatment of pheochromocytoma in children
Ludwig, A. D., Feig, D. I., Brandt, M. L., Hicks, J. M., Fitch, M. E., & Cass, D. L. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.08.028 · Cited by 74
Valproic Acid Activates Notch1 Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells
Greenblatt, D. Y., Cayo, M. A., Adler, J. T., Ning, L., Haymart, M. R., Kunnimalaiyaan, M., & Chen, H. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181758d0e · Cited by 70
Self-citationApoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002
Kunnimalaiyaan, M., Ndiaye, M. A., & Chen, H. (2006) · Surgery · doi:10.1016/j.surg.2006.06.040 · Cited by 67
Self-citationBaid, S. K., Lai, E. W., Wesley, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00006 · Cited by 63
The role of human achaete-scute homolog-1 in medullary thyroid cancer cells
Sippel, R. S., Carpenter, J. E., Kunnimalaiyaan, M., & Chen, H. (2003) · Surgery · doi:10.1016/s0039-6060(03)00418-5 · Cited by 61
Self-citationMackenzie, I. S., Gurnell, M., Balan, K., Simpson, H., Chatterjee, K., & Brown, M. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0369 · Cited by 45
Frequent Genetic Changes in Childhood Pheochromocytomas
de Krijger, R. R., van Nederveen, F. H., Korpershoek, E., de Herder, W. W., Keizer-Schrama, S. M. P. F. D. M., & Dinjens, W. N. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.017 · Cited by 45
Moley, J. F., Lairmore, T. C., & Phay, J. E. (1999) · Current Problems in Surgery · doi:10.1016/s0011-3840(99)80001-x · Cited by 20
Cited by
Pheochromocytoma and Paraganglioma
Neumann, H. P. H., Young, W. F., & Eng, C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806651 · Cited by 736
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Kunz, P. L., Reidy-Lagunes, D., Anthony, L. B., Bertino, E. M., Brendtro, K., Chan, J. A., Chen, H., Jensen, R. T., Kim, M. K., Klimstra, D. S., et al. (2013) · Pancreas · doi:10.1097/mpa.0b013e31828e34a4 · Cited by 580
Self-citationGenetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Flushing in (neuro)endocrinology
Hannah-Shmouni, F., Stratakis, C. A., & Koch, C. A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9394-8 · Cited by 67
Contemporary nuclear medicine imaging of neuroendocrine tumours
Wong, K. K., Waterfield, R. T., Marzola, M. C., Scarsbrook, A. F., Chowdhury, F. U., Gross, M. D., & Rubello, D. (2012) · Clinical Radiology · doi:10.1016/j.crad.2012.03.019 · Cited by 45
Metadata
- Authors
- Chen, H., Sippel, R. S., O'Dorisio, M. S., Vinik, A. I., Lloyd, R. V., & Pacak, K.
- Venue
- Pancreas
- Published
- 2010-08
- Volume
- 39
- Issue
- 6
- Pages
- 775-783
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W271610095
- Cited by
- 593
- References
- 60
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.